Phenibut HCL: Anxiety Research & Benefits

`markdown

Phenibut HCL Anxiety Research: A Comprehensive Overview

Phenibut HCL, also known as β-phenyl-γ-aminobutyric acid hydrochloride, is a central nervous system depressant initially synthesized in the Soviet Union during the 1960s. It is a derivative of the naturally occurring inhibitory neurotransmitter gamma-aminobutyric acid (GABA). Scientists created phenibut by adding a phenyl ring to GABA, which allows it to cross the blood-brain barrier more easily. While primarily known for its anxiolytic effects, phenibut is also used to improve sleep, reduce tension, and enhance cognitive function. Consequently, research into its efficacy and safety regarding anxiety management is crucial. However, it’s vital to approach phenibut with caution due to the potential for dependence and withdrawal.

View Product

The Neurochemical Action of Phenibut

Phenibut’s primary mechanism of action involves modulating GABAergic neurotransmission. GABA is the chief inhibitory neurotransmitter in the mammalian central nervous system, playing a vital role in reducing neuronal excitability throughout the nervous system. Here’s how it works:

GABA-B Receptor Agonist: Phenibut primarily acts as an agonist at the GABA-B receptors. By binding to these receptors, it enhances the inhibitory effects of GABA, thereby reducing neuronal activity. This process contributes to the anxiolytic, sedative, and muscle-relaxant properties of phenibut. This potent activity suggests it could be helpful for treating anxiety but careful dosing is needed.

GABA-A Receptor Involvement: While Phenibut HCL primarily targets GABA-B receptors, some evidence suggests that it might also weakly interact with GABA-A receptors at higher concentrations. However, the GABA-B receptor binding is considered the key driver of its therapeutic and side effect profile.

Dopamine Release: In addition to its GABAergic effects, phenibut can also stimulate dopamine release, particularly at lower doses. This effect contributes to its mood-enhancing properties and can lead to feelings of euphoria in some users. Therefore, this dopaminergic activity can potentially increase the risk of abuse.

Understanding these neurochemical actions is essential for interpreting the research findings on phenibut’s effectiveness and potential risks in anxiety management.

Animal Studies: Exploring Phenibut’s Anxiolytic Potential

Preclinical studies using animal models have provided valuable insights into phenibut’s effects on anxiety-related behaviors. These studies often involve behavioral tests designed to assess anxiety levels in rodents, shedding light on the drug’s potential mechanisms and efficacy.

Elevated Plus Maze (EPM): The Elevated Plus Maze is a widely used test to measure anxiety-like behavior in rodents. It consists of two open arms and two closed arms elevated above the ground. Anxious rodents typically spend more time in the closed arms, while anxiolytic compounds increase the time spent in the open arms. Studies have shown that phenibut administration leads to a significant increase in the time rodents spend in the open arms, indicating a reduction in anxiety.

Researchers have observed a dose-dependent response, with optimal anxiolytic effects achieved at moderate doses. Very high doses can sometimes lead to sedation, confounding the anxiety assessment. This dose-response relationship helps define an effective therapeutic window.

Light-Dark Box Test: The light-dark box test is another common paradigm for assessing anxiety. This test involves a two-compartment box, one brightly lit and the other dark. Rodents generally prefer the dark compartment due to their natural aversion to brightly lit, open spaces. Anxiolytic drugs increase the time spent in the lit compartment, reflecting a decrease in anxiety.

Research has demonstrated that phenibut significantly increases the time rodents spend in the lit compartment, suggesting reduced anxiety levels. The test also evaluates other parameters, such as the number of transitions between the light and dark compartments, which further supports the anxiolytic effect of phenibut.

Social Interaction Test: The social interaction test evaluates anxiety by measuring the duration and frequency of social interactions between rodents. Anxious animals tend to exhibit reduced social interaction. Studies using phenibut have shown varying results. However, some data suggest that at certain doses, phenibut can increase social interaction, indicating a potential reduction in social anxiety.

Notably, the effects might vary depending on the specific experimental conditions, such as the novelty of the environment and the familiarity of the interacting animals. Therefore, the outcomes of these studies should be interpreted with context.

Overall, animal studies suggest that phenibut has consistent anxiolytic effects, particularly in models like the elevated plus maze and light-dark box tests. Consequently, this evidence supports its potential use in managing anxiety, although further research, especially clinical trials, is necessary.

Human Clinical Studies: Assessing Phenibut’s Efficacy and Safety

While animal studies provide valuable preliminary evidence, human clinical trials are essential to determine the efficacy and safety of phenibut in treating anxiety disorders. Unfortunately, robust, well-controlled clinical trials with phenibut are limited, primarily due to the drug’s status as a dietary supplement in many countries, which reduces the incentive for pharmaceutical companies to invest in extensive research.

Early Soviet-Era Studies: Much of the initial clinical research on phenibut originated in the Soviet Union. These studies reported positive effects of phenibut in reducing anxiety, improving sleep, and alleviating tension in patients with various neuropsychiatric conditions. While these early findings are encouraging, they often lack the methodological rigor of modern clinical trials, with smaller sample sizes and less standardized assessment measures.

Despite these limitations, the Soviet-era studies provide valuable insights into the potential therapeutic benefits of phenibut. Many current users and clinicians base their understanding of phenibut’s effects on these historical observations.

Anxiety and Sleep Disorders: Some studies have explored the use of phenibut in patients with generalized anxiety disorder and insomnia. These trials suggest that phenibut can reduce anxiety symptoms and improve sleep quality. However, the evidence is limited by the small number of studies and the absence of large, randomized, placebo-controlled trials.

One area of research has focused on preoperative anxiety. Preliminary results suggest that phenibut may help reduce anxiety levels before surgical procedures, similar to benzodiazepines. Further research is required to confirm these findings and determine the optimal dosage and safety profile.

Comparison with Other Anxiolytics: There is limited research directly comparing phenibut with other established anxiolytic medications, such as benzodiazepines or selective serotonin reuptake inhibitors (SSRIs). Such comparative studies would be valuable in understanding the relative efficacy and safety of phenibut as an alternative treatment option.

Side Effects and Tolerability: Clinical studies have reported that phenibut is generally well-tolerated at therapeutic doses, with common side effects including drowsiness, fatigue, and dizziness. However, the risk of dependence and withdrawal symptoms is a significant concern, particularly with long-term use and high doses.

There is also evidence that phenibut can interact with other central nervous system depressants, such as alcohol and benzodiazepines, potentially increasing the risk of adverse effects. Therefore, caution should be exercised when combining phenibut with other psychoactive substances.

In summary, the clinical evidence supporting the use of phenibut for anxiety management is limited and requires further investigation. Larger, well-designed clinical trials are needed to confirm its efficacy, assess its long-term safety, and compare it with other treatment options.

The Dark Side: Dependence, Tolerance, and Withdrawal

Despite its potential anxiolytic benefits, the use of phenibut comes with significant risks, particularly concerning dependence, tolerance, and withdrawal. Understanding these risks is critical for individuals considering or currently using phenibut for anxiety or other purposes.

Dependence: Phenibut has a high potential for causing psychological and physical dependence. Regular use, especially at higher doses, can lead to the brain adapting to the presence of the drug and reducing its natural production of GABA. This adaptation results in the user experiencing withdrawal symptoms upon cessation of phenibut use.

The risk of dependence is particularly high in individuals with a history of substance abuse or those who use phenibut recreationally to achieve euphoric effects. Consequently, these individuals may rapidly escalate their dose and frequency of use, increasing their likelihood of becoming dependent.

Tolerance: Tolerance to phenibut develops rapidly with regular use. Individuals may find that the initial dose that provided significant anxiety relief or improved sleep becomes less effective over time. As a result, they may increase their dose to achieve the same effects, further exacerbating the risk of dependence and withdrawal.

Tolerance is thought to occur due to changes in the sensitivity and density of GABA-B receptors in the brain. Prolonged stimulation of these receptors by phenibut can lead to downregulation, reducing their response to both phenibut and endogenous GABA.

Withdrawal Symptoms: Phenibut withdrawal can be severe and potentially life-threatening. Symptoms may include rebound anxiety, insomnia, agitation, hallucinations, and seizures. The severity and duration of withdrawal depend on the dose, frequency, and duration of phenibut use.

Withdrawal symptoms typically begin within 12-24 hours after the last dose and can last for several days to weeks. Due to the severity of these symptoms, it is generally recommended to taper the dose of phenibut gradually under medical supervision to minimize the risk of severe withdrawal complications.

Some individuals may require hospitalization and medical management during phenibut withdrawal, particularly those with a history of high-dose use or pre-existing psychiatric conditions. Treatment typically involves supportive care, such as intravenous fluids, sedatives, and anticonvulsants, to manage withdrawal symptoms and prevent complications.

Given these significant risks, phenibut should only be used under the guidance of a healthcare professional. Individuals should be educated about the potential for dependence, tolerance, and withdrawal and closely monitored for signs of these complications. Alternative treatments for anxiety disorders with lower abuse potential should also be considered.

Responsible Use Strategies: Mitigating Risks

If phenibut is considered for anxiety management, implementing responsible use strategies is crucial to minimize the risk of dependence, tolerance, and withdrawal. The following guidelines can help reduce potential harms:

Consult a Healthcare Professional: Before starting phenibut, consult with a healthcare provider, particularly a psychiatrist or addiction specialist. They can evaluate the appropriateness of phenibut for your specific condition, assess potential risks and benefits, and provide guidance on proper dosing and monitoring.

Start with a Low Dose: Begin with the lowest effective dose and gradually increase it only if necessary. Avoid exceeding the recommended dosage, as higher doses increase the risk of side effects and dependence. A typical starting dose is often around 250-500mg.

Limit Frequency of Use: Avoid using phenibut daily. Limit use to no more than two or three times per week to prevent tolerance and dependence. This allows the brain to recover and maintain its natural GABAergic balance.

Avoid Combining with Other Depressants: Do not combine phenibut with alcohol, benzodiazepines, opioids, or other central nervous system depressants. These substances can potentiate the effects of phenibut, increasing the risk of respiratory depression, sedation, and overdose.

Monitor for Side Effects: Closely monitor yourself for any adverse effects, such as drowsiness, dizziness, nausea, or cognitive impairment. If side effects occur, reduce the dose or discontinue use and consult with your healthcare provider.

Taper Gradually: If you have been using phenibut regularly, do not stop abruptly. Taper the dose gradually under medical supervision to minimize withdrawal symptoms. A slow, controlled taper allows the brain to readjust to the absence of phenibut and reduces the severity of withdrawal.

Seek Support: If you experience difficulty controlling your phenibut use or develop withdrawal symptoms, seek help from a healthcare professional or addiction specialist. Support groups and counseling can also provide valuable assistance in managing phenibut dependence and withdrawal.

Explore Alternative Treatments: Consider alternative treatments for anxiety disorders, such as cognitive-behavioral therapy (CBT), mindfulness-based practices, and other anxiolytic medications with lower abuse potential. These approaches can provide effective relief from anxiety without the risks associated with phenibut.

By following these responsible use strategies, individuals can minimize the potential risks associated with phenibut and maximize its potential benefits in managing anxiety. It’s crucial to remember that phenibut is not a long-term solution for anxiety and should be used cautiously under medical supervision.

Conclusion: A Balanced Perspective on Phenibut for Anxiety

Phenibut HCL possesses anxiolytic properties that may benefit individuals struggling with anxiety disorders. Its mechanism of action, involving GABA-B receptor agonism and dopamine modulation, offers a unique approach to anxiety management. However, the limited clinical evidence and significant risks associated with dependence, tolerance, and withdrawal necessitate a cautious and informed approach to its use.
Animal studies have demonstrated consistent anxiolytic effects, providing a basis for its potential efficacy. However, more extensive and well-designed clinical trials are needed to confirm these findings and assess its long-term safety. Early Soviet-era studies offer insights into its potential benefits, but modern research methodologies are essential to validate these observations.
The risks associated with phenibut, particularly dependence and withdrawal, cannot be overstated. These complications can be severe and potentially life-threatening, necessitating careful monitoring and responsible use strategies. Individuals considering phenibut should consult with a healthcare professional to assess its appropriateness and receive guidance on proper dosing and monitoring.
Responsible use strategies, including starting with a low dose, limiting frequency of use, avoiding combinations with other depressants, and tapering gradually under medical supervision, can help mitigate the risks associated with phenibut. Individuals should also be aware of the potential for side effects and seek support if they experience difficulty controlling their use or develop withdrawal symptoms.
Ultimately, phenibut should be considered as one of several treatment options for anxiety, with careful consideration given to its potential risks and benefits. Alternative treatments, such as CBT and other anxiolytic medications with lower abuse potential, should also be explored. With a balanced perspective and responsible approach, individuals can make informed decisions about the use of phenibut in managing anxiety.
`

Phenibut HCL Anxiety Research: A Deep Dive

Phenibut HCL, or β-phenyl-γ-aminobutyric acid hydrochloride, stands out as a synthetic nootropic substance with purported anxiolytic properties. It is essentially a derivative of gamma-aminobutyric acid (GABA), a naturally occurring neurotransmitter in the brain. GABA functions primarily as an inhibitory neurotransmitter, meaning it helps to reduce neuronal excitability throughout the nervous system. Phenibut’s unique structure allows it to cross the blood-brain barrier more effectively than GABA alone, potentially leading to pronounced effects on mood, anxiety, and cognitive function. This section will provide a detailed exploration of research related to phenibut HCL and its effects on anxiety, encompassing preclinical and clinical studies, its mechanism of action, safety considerations, and potential risks.

Preclinical Studies on Phenibut HCL and Anxiety

Preclinical studies, primarily involving animal models, have played a crucial role in understanding the potential therapeutic effects of phenibut HCL on anxiety. These studies often utilize established behavioral tests designed to assess anxiety-like behaviors in animals. These tests provide valuable insights into how phenibut might affect humans suffering from anxiety disorders.

Elevated Plus Maze (EPM)

The Elevated Plus Maze (EPM) is a common and widely validated test used to evaluate anxiety-like behavior in rodents. The maze consists of four arms arranged in a plus shape, with two open arms and two closed arms. Anxious animals tend to spend more time in the closed arms, as these provide a sense of security. Conversely, a reduction in anxiety is typically indicated by an increase in the time spent exploring the open arms.
Research using the EPM has demonstrated that phenibut administration can lead to anxiolytic effects in rodents. Specifically, studies have shown that animals treated with phenibut spend a significantly greater amount of time in the open arms of the EPM compared to control groups. This suggests that phenibut reduces anxiety-like behavior in these animals. Moreover, these studies often compare phenibut’s effects to those of established anxiolytic drugs like diazepam (Valium), with some studies reporting comparable or even superior anxiolytic effects with phenibut at certain doses [1]. However, the efficacy is very dose-dependent.

Social Interaction Test

The social interaction test assesses anxiety-related behaviors in the context of social interactions between animals. Anxious animals typically exhibit reduced social interaction, while a decrease in anxiety is reflected by increased social interactions.
Some research indicates that phenibut may influence social behavior, potentially due to its anxiolytic effects. However, findings can be variable. Some studies report that phenibut increases social interaction among rodents. Other studies report that phenibut did not significantly increase the amount of social contact among test subjects, indicating that the anxiolytic effect that it exhibits may differ from that of diazepam [1]. Thus, further research is warranted.

Light/Dark Box Test

The Light/Dark Box test is another widely used paradigm for evaluating anxiety in rodents. This test leverages the natural aversion of rodents to brightly lit open spaces, juxtaposed with their preference for dark, enclosed areas. Animals are placed in a box divided into a brightly lit compartment and a dark compartment. Anxious animals tend to spend more time in the dark compartment, while a decrease in anxiety is indicated by an increased willingness to explore the light compartment.
Studies using the Light/Dark Box test have shown that phenibut can reduce anxiety-like behavior in rodents. For instance, one study found that rats treated with phenibut displayed a greater propensity to enter and spend time in the light compartment compared to control animals [2]. This finding suggests that phenibut decreases the animals’ aversion to the aversive bright environment, indicating an anxiolytic effect.

Clinical Studies on Phenibut HCL and Anxiety

While preclinical studies provide valuable insights into the potential effects of phenibut HCL, clinical studies involving human subjects are essential for determining its efficacy and safety in treating anxiety disorders. Unfortunately, the number of well-designed, controlled clinical trials investigating phenibut’s anxiolytic effects is limited, but some studies have shown promise.

Early Clinical Trials

Some of the earlier clinical research on phenibut was conducted in Russia and other Eastern European countries. These studies suggested that phenibut can be effective in reducing anxiety symptoms in individuals with various anxiety disorders, including generalized anxiety disorder (GAD) and social anxiety disorder (SAD). Additionally, Phenibut was found to reduce the frequency, duration, and intensity of tension-type headaches, while reducing anxiety and sleep disorders [3].

Limitations of Existing Clinical Data

It is crucial to acknowledge the limitations of the current clinical data on phenibut HCL and anxiety. Many of the existing studies are limited by small sample sizes, lack of rigorous controls, and publication in languages other than English, making it difficult for researchers in Western countries to evaluate the findings thoroughly. Furthermore, some studies lack detailed information about the specific diagnostic criteria used to define anxiety disorders, which can affect the interpretation of results.
Therefore, while preliminary clinical evidence suggests that phenibut may have anxiolytic properties, more well-designed, controlled trials are needed to confirm these findings and determine the optimal dosing regimens and safety profiles for specific anxiety disorders.

Mechanism of Action

Phenibut HCL’s anxiolytic effects are believed to stem from its influence on several neurotransmitter systems in the brain, most notably the GABAergic and dopaminergic systems.

GABAergic System

As a GABA analogue, phenibut primarily exerts its effects by interacting with GABA receptors. GABA is the primary inhibitory neurotransmitter in the brain, and its activation leads to a reduction in neuronal excitability. Phenibut binds to GABA receptors, particularly the GABA-B subtype, enhancing GABA’s inhibitory actions. This GABA-B receptor agonism is thought to be responsible for phenibut’s calming, anxiolytic, and sedative effects. This mechanism mirrors that of other anxiolytics, suggesting that it exerts its anxiety-relieving effects using a mechanism familiar to researchers [2][4].

Dopaminergic System

In addition to its GABAergic activity, phenibut also influences the dopaminergic system. Dopamine is a neurotransmitter involved in reward, motivation, and motor control. Phenibut can increase dopamine levels in the brain, particularly at lower doses. This dopaminergic activity may contribute to the mood-enhancing and euphoric effects reported by some individuals who take phenibut. However, at higher doses, phenibut’s effects on dopamine can become more complex and may even lead to dopamine depletion, which could contribute to withdrawal symptoms and dependence. The increased dopamine could also be a contributor to phenibut abuse, and the rewarding nature of the drug [2][4].

NMDA Receptor Interaction

Phenibut has also been found to interact with N-methyl-D-aspartate (NMDA) receptors, which are glutamate receptors involved in learning and memory. Phenibut acts as an NMDA receptor antagonist, meaning it blocks the activation of these receptors. This NMDA antagonism may contribute to phenibut’s anxiolytic effects, as excessive NMDA receptor activity has been implicated in anxiety and excitotoxicity. This mechanism means that it likely possesses sedative properties [4].

Synergistic Effects

The combination of phenibut’s effects on GABA, dopamine, and NMDA receptors likely contributes to its overall anxiolytic profile. However, the precise interplay between these neurotransmitter systems is complex and not fully understood. Further research is needed to elucidate the relative contributions of each system to phenibut’s therapeutic and adverse effects.

Safety Considerations and Potential Risks

While phenibut HCL may offer anxiolytic benefits, it is essential to be aware of its potential risks and safety considerations. These include the risk of tolerance, dependence, withdrawal symptoms, and potential interactions with other medications.

Tolerance and Dependence

One of the most significant concerns with phenibut is the development of tolerance and dependence. With regular use, the brain can adapt to phenibut’s effects, leading to a gradual reduction in its efficacy. As tolerance develops, individuals may be tempted to increase their dosage to achieve the same effects, further exacerbating the risk of dependence. This dependence manifests in both physical and psychological symptoms, leading to an addiction.

Withdrawal Symptoms

Abruptly discontinuing phenibut after prolonged use can trigger a withdrawal syndrome characterized by a range of unpleasant and potentially dangerous symptoms, including:

Anxiety: Paradoxically, anxiety is a common withdrawal symptom, often manifesting as rebound anxiety that is more severe than the initial anxiety being treated.

Insomnia: Difficulty sleeping is another frequent withdrawal symptom.

Agitation: Restlessness and irritability are common during withdrawal.

Tremors: Shaking or trembling may occur.

Seizures: In severe cases, withdrawal can lead to seizures, highlighting the importance of gradual tapering under medical supervision.

Psychosis: Some case reports indicate that psychosis can occur during phenibut withdrawal.

The severity of withdrawal symptoms can vary depending on the dosage, duration of use, and individual factors. To minimize the risk of withdrawal, it is crucial to taper phenibut gradually under the guidance of a healthcare professional. This professional monitoring can ensure a smooth and safe detox [4][5].

Interactions with Other Medications

Phenibut can interact with other medications, particularly those that also affect the central nervous system, such as:

Benzodiazepines: Combining phenibut with benzodiazepines (e.g., diazepam, alprazolam) can increase the risk of sedation, respiratory depression, and overdose.

Alcohol: Alcohol also enhances GABAergic activity, and combining it with phenibut can lead to excessive sedation and impaired cognitive and motor function.

Opioids: Opioids, such as morphine and oxycodone, can interact with phenibut to increase the risk of respiratory depression and overdose.

Individuals taking any of these medications should consult with a healthcare professional before using phenibut.

Limited Regulatory Oversight

In many countries, phenibut is not subject to strict regulatory oversight, meaning it can be readily purchased online without a prescription. This lack of regulation can increase the risk of misuse, abuse, and exposure to contaminated or counterfeit products. It also means that manufacturers may not adhere to strict quality control standards, potentially leading to inconsistencies in product potency and purity. It also removes access to professional help, which is necessary to reduce dependence.

Potential for Abuse

Given its anxiolytic, mood-enhancing, and sedative effects, phenibut has the potential for abuse, particularly among individuals seeking to self-medicate anxiety or other mental health conditions.

View Product
The euphoric effects experienced by some users can further contribute to its addictive potential. It is essential to use phenibut responsibly and only under the guidance of a healthcare professional.

Responsible Use of Phenibut HCL

If considering phenibut HCL for anxiety, it is crucial to adhere to the following guidelines:

Consult with a Healthcare Professional: Discuss the potential risks and benefits with a qualified healthcare professional before starting phenibut.

Start with a Low Dose: Begin with the lowest effective dose and gradually increase it as needed, under medical supervision.

Use Infrequently: Avoid daily or prolonged use to minimize the risk of tolerance and dependence.

Avoid Combining with Other CNS Depressants: Do not take phenibut with alcohol, benzodiazepines, or other sedatives.

Taper Gradually: If discontinuing phenibut after regular use, taper the dose gradually under medical supervision to minimize withdrawal symptoms.

Purchase from Reputable Sources: Obtain phenibut from reputable sources that adhere to quality control standards.

Monitor for Side Effects: Be aware of potential side effects and seek medical attention if they occur.

The Future of Phenibut HCL Research

Despite the limitations of the current research, there is a continued interest in exploring the potential therapeutic applications of phenibut HCL. Future research should focus on:

Well-Designed Clinical Trials: Conducting larger, well-controlled clinical trials to evaluate the efficacy and safety of phenibut for specific anxiety disorders.

Mechanism of Action Studies: Further elucidating the precise mechanisms by which phenibut exerts its effects on the brain.

Long-Term Safety Studies: Assessing the long-term safety and tolerability of phenibut, including its potential for dependence and withdrawal.

Dosage Optimization Studies: Determining the optimal dosing regimens for different anxiety disorders, taking into account individual factors such as age, weight, and medical history.

Comparative Studies: Comparing phenibut to other anxiolytic medications to determine its relative efficacy and safety.

Summary

Phenibut HCL has garnered attention as a potential anxiolytic agent, with both preclinical and clinical studies suggesting it may reduce anxiety symptoms. Its mechanism of action involves modulating the GABAergic, dopaminergic, and NMDA receptor systems. However, the current evidence base is limited, and more rigorous research is needed to confirm its efficacy and safety. The use of phenibut is associated with significant risks, including tolerance, dependence, withdrawal symptoms, and potential interactions with other medications. Therefore, phenibut should only be used under the guidance of a healthcare professional, with careful consideration of the potential risks and benefits. It’s important to use other methods, such as meditation or exercise, to reduce anxiety.

References

Maze Conduct Science: Phenibut: A Nootropic Needing More Behavioral Studies.

California Prime Recovery: Phenibut History, Mechanisms, Side Effects, Risks.

Magistralbr: Safety and Tolerability of the Anxiolytic and Nootropic Drug Phenibut.

Fullscript: Phenibut: Dosage, Side Effects, and Supplements.

PubMed: Safety and Tolerability of the Anxiolytic and Nootropic Drug Phenibut.